Discontinued — last reported Q4 '16

Amount that if recognized, would affect the effective tax rate or regulatory liability

Vertex Pharmaceuticals Amount that if recognized, would affect the effective tax rate or regulatory liability decreased by 3.7% to $420.30M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryRisk

SignalLower is better

VolatilityModerate

First reportedQ4 2015

Last reportedQ4 2016

How to read this metric

A high value indicates significant potential volatility in the effective tax rate based on future tax authority rulings.

Detailed definition

This represents the portion of unrecognized tax benefits that, if recognized, would directly impact the company's effect...

Peer comparison

Standard disclosure for public companies; utility peers typically maintain low levels due to the regulated nature of their tax recovery.

Metric ID: other_unrecognized_tax_benefits_that_would_impact_effect_ff36cb

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$436.60M	$420.30M
QoQ Change	—	-3.7%

Range$420.30M – $436.60M

Frequently Asked Questions

What is Vertex Pharmaceuticals's amount that if recognized, would affect the effective tax rate or regulatory liability?: Vertex Pharmaceuticals (VRTX) reported amount that if recognized, would affect the effective tax rate or regulatory liability of $420.30M in Q1 2026.
What does amount that if recognized, would affect the effective tax rate or regulatory liability mean?: The portion of uncertain tax benefits that would directly increase or decrease the company's reported tax expense if confirmed.